Cargando…
Protectin DX as a therapeutic strategy against frailty in mice
Frailty in aging is driven by the dysregulation of multiple biological pathways. Protectin DX (PDX) is a docosahexaenoic acid (DHA)-derived molecule that alleviates many chronic inflammatory disorders, but its potential effects on frailty remain unknown. Our goal is to identify age-related impairmen...
Autores principales: | Perazza, Laís R., Gower, Adam C., Brown-Borg, Holly M., Pajevic, Paola Divieti, Thompson, LaDora V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651819/ https://www.ncbi.nlm.nih.gov/pubmed/37059838 http://dx.doi.org/10.1007/s11357-023-00789-3 |
Ejemplares similares
-
Anti-inflammatory and anti-virus potential of poxytrins, especially protectin DX
por: Lagarde, Michel, et al.
Publicado: (2020) -
Frailty: Past, present, and future?
por: Kwak, Dongmin, et al.
Publicado: (2020) -
Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis
por: White, Phillip J., et al.
Publicado: (2014) -
Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice
por: Li, Hui, et al.
Publicado: (2017) -
Protectin DX Relieve Hyperoxia‐induced Lung Injury by Protecting Pulmonary Endothelial Glycocalyx
por: Liang, Zhongjie, et al.
Publicado: (2023)